Wealthstreet Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-23,772
Closed -$10.8M 302
2021
Q1
$10.8M Sell
23,772
-645
-3% -$308K 1.06% 23
2020
Q4
$11.4M Sell
24,417
-2,125
-8% -$996K 1.15% 22
2020
Q3
$11.7M Sell
26,542
-1,572
-6% -$649K 1.31% 21
2020
Q2
$10.2M Sell
28,114
-269
-0.9% -$90.2K 1.25% 21
2020
Q1
$8.05M Sell
28,383
-100
-0.4% -$31.5K 1.19% 22
2019
Q4
$9.25M Sell
28,483
-408
-1% -$124K 1.08% 23
2019
Q3
$8.61M Sell
28,891
-265
-0.9% -$75.9K 1.1% 24
2019
Q2
$8.56M Sell
29,156
-565
-2% -$156K 1.11% 21
2019
Q1
$8.13M Sell
29,721
-305
-1% -$75.9K 1.07% 21
2018
Q4
$7.14M Sell
30,026
-1,373
-4% -$322K 1% 25
2018
Q3
$7.66M Sell
31,399
-623
-2% -$143K 0.95% 25
2018
Q2
$6.63M Hold
32,022
0.88% 27
2018
Q1
$6.61M Buy
32,022
+869
+3% +$182K 0.83% 28
2017
Q4
$5.92M Buy
+31,153
New +$5.97M 0.72% 32

Other funds holding TMO

Wealthstreet Investment Advisors's TMO Position: Q2 2021 in Review

Wealthstreet Investment Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2021, closing a stake of 23,772 shares — an estimated $10.8M sold.

Wealthstreet Investment Advisors first reported a position in TMO in Q4 2017 and held it in 14 quarters. The position peaked at $11.7M in Q3 2020. 2,076 funds tracked by Wall St. Rank hold TMO as of Q2 2021.

  • Wealthstreet Investment Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2021 after selling out during the quarter.
  • Wealthstreet Investment Advisors sold 23,772 Thermo Fisher Scientific shares in Q2 2021, an estimated $10.8M.
  • Wealthstreet Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2017 and held it in 14 quarters.
  • Wealthstreet Investment Advisors's Thermo Fisher Scientific position peaked at $11.7M in Q3 2020.
  • 2,076 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2021.

Based on Wealthstreet Investment Advisors's 13F filing for Q2 2021, filed 2 Aug 2021.